Westlake Chemical Partners LP Hits New 52-Week Low at $18.93

Westlake Chemical Partners LP has reached a new 52-week low, trading at USD 18.93 as of October 29, 2025. This marks a significant decline for the specialty chemicals company, which has seen its stock price decrease by 16.45% over the past year, contrasting sharply with the S&P 500's performance of 18.33% during the same period.
The company operates within the microcap segment, boasting a market capitalization of USD 774 million. Westlake Chemical Partners LP has a price-to-earnings (P/E) ratio of 2.00, indicating a valuation that is notably lower than many of its industry peers. Despite a strong return on equity of 63.29%, the company has faced challenges, including a decline in operating profit at an annual rate of -1.43% over the last five years.

Financial metrics reveal a low debt-to-EBITDA ratio of 0.74, suggesting a solid capacity to manage debt. However, the company has reported negative results recently, with a net profit of USD 19.51 million reflecting a decline of 33.34%. As Westlake Chemical Partners LP navigates these financial dynamics, its recent stock performance underscores the complexities within the specialty chemicals sector.